Parsons Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Hold |
2,755
| – | – | 0.01% | 418 |
|
|
2025
Q1 | $223K | Hold |
2,755
| – | – | 0.01% | 411 |
|
|
2024
Q4 | $248K | Buy |
2,755
+75
| +3% | +$6.76K | 0.01% | 404 |
|
|
2024
Q3 | $265K | Hold |
2,680
| – | – | 0.02% | 399 |
|
|
2024
Q2 | $248K | Hold |
2,680
| – | – | 0.02% | 404 |
|
|
2024
Q1 | $254K | Buy |
2,680
+30
| +1% | +$2.85K | 0.02% | 398 |
|
|
2023
Q4 | $237K | Buy |
+2,650
| New | +$237K | 0.02% | 399 |
|
|
2023
Q3 | – | Sell |
-2,650
| Closed | -$220K | – | 432 |
|
|
2023
Q2 | $220K | Hold |
2,650
| – | – | 0.02% | 401 |
|
|
2023
Q1 | $202K | Hold |
2,650
| – | – | 0.02% | 409 |
|
|
2022
Q4 | $220K | Hold |
2,650
| – | – | 0.02% | 396 |
|
|
2022
Q3 | $210K | Buy |
+2,650
| New | +$210K | 0.02% | 395 |
|
|
2021
Q3 | – | Sell |
-1,550
| Closed | -$210K | – | 434 |
|
|
2021
Q2 | $210K | Sell |
1,550
-65
| -4% | -$8.81K | 0.02% | 399 |
|
|
2021
Q1 | $219K | Buy |
+1,615
| New | +$219K | 0.02% | 389 |
|